Advisors Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,117
| Closed | -$1.23M | – | 1533 |
|
|
2022
Q3 | $1.23M | Sell |
8,117
-555
| -6% | -$83.9K | 0.03% | 651 |
|
|
2022
Q2 | $1.26M | Sell |
8,672
-14,966
| -63% | -$2.18M | 0.02% | 667 |
|
|
2022
Q1 | $2.8M | Sell |
23,638
-1,413
| -6% | -$168K | 0.04% | 467 |
|
|
2021
Q4 | $3.45M | Buy |
25,051
+191
| +0.8% | +$26.3K | 0.05% | 421 |
|
|
2021
Q3 | $3.45M | Buy |
24,860
+825
| +3% | +$115K | 0.05% | 394 |
|
|
2021
Q2 | $2.33M | Buy |
24,035
+2,232
| +10% | +$217K | 0.03% | 549 |
|
|
2021
Q1 | $1.49M | Buy |
21,803
+1,368
| +7% | +$93.5K | 0.02% | 690 |
|
|
2020
Q4 | $1.75M | Buy |
20,435
+6,354
| +45% | +$544K | 0.03% | 606 |
|
|
2020
Q3 | $915K | Buy |
14,081
+8,964
| +175% | +$582K | 0.02% | 733 |
|
|
2020
Q2 | $374K | Buy |
+5,117
| New | +$374K | 0.01% | 994 |
|